KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Non Operating Income (2016 - 2026)

Bio-Rad Laboratories has reported Non Operating Income over the past 18 years, most recently at $24.2 million for Q1 2026.

  • Quarterly Non Operating Income fell 34.95% to $24.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $77.3 million through Mar 2026, down 16.79% year-over-year, with the annual reading at $90.3 million for FY2025, 0.0% changed from the prior year.
  • Non Operating Income was $24.2 million for Q1 2026 at Bio-Rad Laboratories, down from $28.6 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $50.4 million in Q1 2023 and troughed at $2.3 million in Q4 2022.
  • The 5-year median for Non Operating Income is $19.1 million (2023), against an average of $20.9 million.
  • The largest YoY upside for Non Operating Income was 7079.17% in 2022 against a maximum downside of 76.85% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $2.3 million in 2022, then soared by 719.39% to $19.1 million in 2023, then rose by 2.62% to $19.6 million in 2024, then skyrocketed by 45.92% to $28.6 million in 2025, then dropped by 15.38% to $24.2 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Non Operating Income are $24.2 million (Q1 2026), $28.6 million (Q4 2025), and $8.3 million (Q3 2025).